成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> ACS Applied Energy Materials >>article
ACS Applied Energy Materials

ACS Applied Energy Materials

IF: 5.4
Download PDF

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.

Published:29 October 2021 DOI: 10.3390/molecules26216531 PMID: 34770940
María Jesús Friedli, Nibaldo C Inestrosa

Abstract

Huperzine A (HupA), an alkaloid found in the club moss Huperzia serrata, has been used for centuries in Chinese folk medicine to treat dementia. The effects of this alkaloid have been attributed to its ability to inhibit the cholinergic enzyme acetylcholinesterase (AChE), acting as an acetylcholinesterase inhibitor (AChEI). The biological functions of HupA have been studied both in vitro and in vivo, and its role in neuroprotection appears to be a good therapeutic candidate for Alzheimer′s disease (AD). Here, we summarize the neuroprotective effects of HupA on AD, with an emphasis on its interactions with different molecular signaling avenues, such as the Wnt signaling, the pre- and post-synaptic region mechanisms (synaptotagmin, neuroligins), the amyloid precursor protein (APP) processing, the amyloid-β peptide (Aβ) accumulation, and mitochondrial protection. Our goal is to provide an integrated overview of the molecular mechanisms through which HupA affects AD.

Substances (7)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Ammonium polyphosphate 68333-79-9 H12N3O4P 333 suppliers $45.00-$729.00
Amyloid β-Peptide (1-42) (human) 107761-42-2 C203H311N55O60S1 308 suppliers $91.00-$1389.56
Huperzine A 120786-18-7 C15H18N2O 199 suppliers $62.00-$1200.00
Anticholinesterase 9000-81-1 NULL 155 suppliers $95.00-$1110.00
Wnt Signaling Antibody Sampler Kit 12 suppliers Inquiry
Amyloid Precursor Protein (APP) (44-62) 5 suppliers Inquiry
1 suppliers Inquiry

Similar articles

IF:3.5

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease

Journal of Food Biochemistry Ahsas Goyal, Aanchal Verma,etc Published: 15 September 2022
IF:3.2

Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.

Neuropsychiatric Disease and Treatment Rajesh R Tampi, Christopher H van Dyck,etc Published: 1 April 2007
IF:3.7

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis

Neurochemical Research Mayuri Shukla, Prapimpun Wongchitrat,etc Published: 5 February 2022